These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 33649846)
21. Antiproliferative effects of ZD0473 (AMD473) in combination with 5-fluorouracil or SN38 in human colorectal cancer cell lines. Plasencia C; Abad A; Martinez-Balibrea E; Taron M Invest New Drugs; 2004 Nov; 22(4):399-409. PubMed ID: 15292710 [TBL] [Abstract][Full Text] [Related]
22. Combination studies of antifolates with 5-fluorouracil in colon cancer cell lines. van der Wilt CL; Kuiper CM; Peters GJ Oncol Res; 1999; 11(8):383-91. PubMed ID: 10803742 [TBL] [Abstract][Full Text] [Related]
23. Different mechanisms of acquired resistance to fluorinated pyrimidines in human colorectal cancer cells. Murakami Y; Kazuno H; Emura T; Tsujimoto H; Suzuki N; Fukushima M Int J Oncol; 2000 Aug; 17(2):277-83. PubMed ID: 10891536 [TBL] [Abstract][Full Text] [Related]
24. Long-term resistance to 5-fluorouracil promotes epithelial-mesenchymal transition, apoptosis evasion, autophagy, and reduced proliferation rate in colon cancer cells. Sousa-Squiavinato ACM; Arregui Ramos DA; Wagner MS; Tessmann JW; de-Freitas-Junior JCM; Morgado-Díaz JA Eur J Pharmacol; 2022 Oct; 933():175253. PubMed ID: 36067803 [TBL] [Abstract][Full Text] [Related]
25. Reduced activity of anabolizing enzymes in 5-fluorouracil-resistant human stomach cancer cells. Inaba M; Mitsuhashi J; Sawada H; Miike N; Naoe Y; Daimon A; Koizumi K; Tsujimoto H; Fukushima M Jpn J Cancer Res; 1996 Feb; 87(2):212-20. PubMed ID: 8609072 [TBL] [Abstract][Full Text] [Related]
26. Transcription and activity of 5-fluorouracil converting enzymes in fluoropyrimidine resistance in colon cancer in vitro. Mader RM; Sieder AE; Braun J; Rizovski B; Kalipciyan M; Mueller MW; Jakesz R; Rainer H; Steger GG Biochem Pharmacol; 1997 Dec; 54(11):1233-42. PubMed ID: 9416974 [TBL] [Abstract][Full Text] [Related]
27. Enhanced DNA-directed effects of FdUMP[10] compared to 5FU. Gmeiner WH; Trump E; Wei C Nucleosides Nucleotides Nucleic Acids; 2004; 23(1-2):401-10. PubMed ID: 15043163 [TBL] [Abstract][Full Text] [Related]
28. Conditioned media from human macrophages of M1 phenotype attenuate the cytotoxic effect of 5‑fluorouracil on the HT‑29 colon cancer cell line. Hedbrant A; Erlandsson A; Delbro D; Wijkander J Int J Oncol; 2015 Jan; 46(1):37-46. PubMed ID: 25310018 [TBL] [Abstract][Full Text] [Related]
29. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer. Toden S; Okugawa Y; Jascur T; Wodarz D; Komarova NL; Buhrmann C; Shakibaei M; Boland CR; Goel A Carcinogenesis; 2015 Mar; 36(3):355-67. PubMed ID: 25653233 [TBL] [Abstract][Full Text] [Related]
30. Potentiation of the antitumor activity of 5-fluorouracil in colon carcinoma cells by the combination of interferon and deoxyribonucleosides results from complementary effects on thymidine phosphorylase. Schwartz EL; Baptiste N; O'Connor CJ; Wadler S; Otter BA Cancer Res; 1994 Mar; 54(6):1472-8. PubMed ID: 8137250 [TBL] [Abstract][Full Text] [Related]
31. IFN gamma-induced up-regulation of PD-ECGF/TP enhances the cytotoxicity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in bladder cancer cells. Li G; Kawakami S; Kageyama Y; Yan C; Saito K; Kihara K Anticancer Res; 2002; 22(5):2607-12. PubMed ID: 12529971 [TBL] [Abstract][Full Text] [Related]
32. Thymidine Kinase 1 Loss Confers Trifluridine Resistance without Affecting 5-Fluorouracil Metabolism and Cytotoxicity. Edahiro K; Iimori M; Kobunai T; Morikawa-Ichinose T; Miura D; Kataoka Y; Niimi S; Wakasa T; Saeki H; Oki E; Kitao H; Maehara Y Mol Cancer Res; 2018 Oct; 16(10):1483-1490. PubMed ID: 29866926 [TBL] [Abstract][Full Text] [Related]
33. Impact of thymidine phosphorylase surexpression on fluoropyrimidine activity and on tumour angiogenesis. Marchetti S; Chazal M; Dubreuil A; Fischel JL; Etienne MC; Milano G Br J Cancer; 2001 Aug; 85(3):439-45. PubMed ID: 11487278 [TBL] [Abstract][Full Text] [Related]
34. Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors. van der Wilt CL; Backus HH; Smid K; Comijn L; Veerman G; Wouters D; Voorn DA; Priest DG; Bunni MA; Mitchell F; Jackman AL; Jansen G; Peters GJ Cancer Res; 2001 May; 61(9):3675-81. PubMed ID: 11325838 [TBL] [Abstract][Full Text] [Related]
35. Corosolic acid reduces 5‑FU chemoresistance in human gastric cancer cells by activating AMPK. Park JB; Lee JS; Lee MS; Cha EY; Kim S; Sul JY Mol Med Rep; 2018 Sep; 18(3):2880-2888. PubMed ID: 30015846 [TBL] [Abstract][Full Text] [Related]
36. Chromosomal imbalance maps of human 5FU-resistant colorectal cancer cell lines: implications in the analysis of 5FU-acquired resistance mechanisms. Plasencia C; Rooney PH; Taron M; Martinez-Balibrea E; McLeod HL; Abad A Int J Oncol; 2003 May; 22(5):945-53. PubMed ID: 12684658 [TBL] [Abstract][Full Text] [Related]
37. Mechanisms for 5-fluorouracil resistance in human colon cancer DLD-1 cells. Inaba M; Naoe Y; Mitsuhashi J Biol Pharm Bull; 1998 Jun; 21(6):569-73. PubMed ID: 9657039 [TBL] [Abstract][Full Text] [Related]
38. Alteration of fluorouracil metabolism in human colon cancer cells by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levels. Grem JL; Fischer PH Cancer Res; 1986 Dec; 46(12 Pt 1):6191-9. PubMed ID: 2946402 [TBL] [Abstract][Full Text] [Related]
39. Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase. Nakamura A; Nakajima G; Okuyama R; Kuramochi H; Kondoh Y; Kanemura T; Takechi T; Yamamoto M; Hayashi K Gastric Cancer; 2014 Jan; 17(1):188-95. PubMed ID: 23494117 [TBL] [Abstract][Full Text] [Related]
40. Influence of chemotherapeutic agents and cytokines on the expression of 5-fluorouracil-associated enzymes in human colon cancer cell lines. Miyazaki K; Shibahara T; Sato D; Uchida K; Suzuki H; Matsui H; Yanaka A; Nakahara A; Matsuzaki Y J Gastroenterol; 2006 Feb; 41(2):140-50. PubMed ID: 16568373 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]